These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 33353556)

  • 21. Altered serum level of metabolic and endothelial factors in patients with systemic sclerosis.
    Stochmal A; Czuwara J; Zaremba M; Rudnicka L
    Arch Dermatol Res; 2020 Aug; 312(6):453-458. PubMed ID: 31667578
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical significance of serum ferritin in patients with systemic sclerosis.
    Jiang Y; Li X; Zhou W; Jin M; Li S; Lao Y; Zhu H; Wang J
    J Clin Lab Anal; 2022 Aug; 36(8):e24597. PubMed ID: 35808930
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High reactive oxygen species in fibrotic and nonfibrotic skin of patients with diffuse cutaneous systemic sclerosis.
    Bourji K; Meyer A; Chatelus E; Pincemail J; Pigatto E; Defraigne JO; Singh F; Charlier C; Geny B; Gottenberg JE; Punzi L; Cozzi F; Sibilia J
    Free Radic Biol Med; 2015 Oct; 87():282-9. PubMed ID: 26143738
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mean platelet volume seems to be a valuable marker in patients with systemic sclerosis.
    Soydinc S; Turkbeyler IH; Pehlivan Y; Soylu G; Goktepe MF; Bilici M; Zengin O; Kisacik B; Onat AM
    Inflammation; 2014 Feb; 37(1):100-6. PubMed ID: 23996103
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endocan, Novel Potential Biomarker for Systemic Sclerosis: Results of a Pilot Study.
    Bălănescu P; Lădaru A; Bălănescu E; Voiosu T; Băicuş C; Dan GA
    J Clin Lab Anal; 2016 Sep; 30(5):368-73. PubMed ID: 26331941
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlation of Th17 cells and CD4⁺CD25⁺ regulatory T cells with clinical parameters in patients with systemic sclerosis.
    Jiang N; Li M; Zeng X
    Chin Med J (Engl); 2014; 127(20):3557-61. PubMed ID: 25316229
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of soluble urokinase plasminogen activator receptor levels with fibrotic and vascular manifestations in systemic sclerosis.
    Butt S; Jeppesen JL; Iversen LV; Fenger M; Eugen-Olsen J; Andersson C; Jacobsen S
    PLoS One; 2021; 16(2):e0247256. PubMed ID: 33617568
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlation between serological biomarkers of extracellular matrix turnover and lung fibrosis and pulmonary artery hypertension in patients with systemic sclerosis.
    Kubo S; Siebuhr AS; Bay-Jensen AC; Juhl P; Karsdal MA; Satoh Y; Todoroki Y; Nakano K; Nakayamada S; Tanaka Y
    Int J Rheum Dis; 2020 Apr; 23(4):532-539. PubMed ID: 32022479
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The clinical relevance of autoantibodies in scleroderma.
    Ho KT; Reveille JD
    Arthritis Res Ther; 2003; 5(2):80-93. PubMed ID: 12718748
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The clinical significance of serum N-terminal pro-brain natriuretic peptide in systemic sclerosis patients.
    Choi HJ; Shin YK; Lee HJ; Kee JY; Shin DW; Lee EY; Lee YJ; Lee EB; Song YW
    Clin Rheumatol; 2008 Apr; 27(4):437-42. PubMed ID: 17899307
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Associations with digital ulcers in a large cohort of systemic sclerosis: results from the Canadian Scleroderma Research Group registry.
    Khimdas S; Harding S; Bonner A; Zummer B; Baron M; Pope J;
    Arthritis Care Res (Hoboken); 2011 Jan; 63(1):142-9. PubMed ID: 20740608
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Autoantibody profiles in systemic sclerosis: predictive value for clinical evaluation and prognosis.
    Hamaguchi Y
    J Dermatol; 2010 Jan; 37(1):42-53. PubMed ID: 20175839
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Deregulation of long noncoding RNAs ANCR, TINCR, HOTTIP and SPRY4-IT1 in plasma of systemic sclerosis patients: SPRY4-IT1 as a novel biomarker of scleroderma and its subtypes.
    Abd-Elmawla MA; Hassan M; Elsabagh YA; Alnaggar ARLR; Senousy MA
    Cytokine; 2020 Sep; 133():155124. PubMed ID: 32442909
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Elevated BALF concentrations of alpha- and beta-defensins in patients with pulmonary alveolar proteinosis.
    Mukae H; Ishimoto H; Yanagi S; Ishii H; Nakayama S; Ashitani J; Nakazato M; Kohno S
    Respir Med; 2007 Apr; 101(4):715-21. PubMed ID: 17000097
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nerve growth factor and neuropeptides circulating levels in systemic sclerosis (scleroderma).
    Matucci-Cerinic M; Giacomelli R; Pignone A; Cagnoni ML; Generini S; Casale R; Cipriani P; Del Rosso A; Tirassa P; Konttinen YT; Kahaleh BM; Fan PS; Paoletti M; Marchesi C; Cagnoni M; Aloe L
    Ann Rheum Dis; 2001 May; 60(5):487-94. PubMed ID: 11302871
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum levels of interleukin-18-binding protein isoform a: Clinical association with inflammation and pulmonary hypertension in systemic sclerosis.
    Nakamura K; Asano Y; Taniguchi T; Minatsuki S; Inaba T; Maki H; Hatano M; Yamashita T; Saigusa R; Ichimura Y; Takahashi T; Toyama T; Yoshizaki A; Miyagaki T; Sugaya M; Sato S
    J Dermatol; 2016 Aug; 43(8):912-8. PubMed ID: 26777734
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antinuclear antibody-negative systemic sclerosis.
    Salazar GA; Assassi S; Wigley F; Hummers L; Varga J; Hinchcliff M; Khanna D; Schiopu E; Phillips K; Furst DE; Steen V; Baron M; Hudson M; Taillefer SS; Pope J; Jones N; Docherty P; Khalidi NA; Robinson D; Simms RW; Silver RM; Frech TM; Fessler BJ; Molitor JA; Fritzler MJ; Segal BM; Al-Kassab F; Perry M; Yang J; Zamanian S; Reveille JD; Arnett FC; Pedroza C; Mayes MD
    Semin Arthritis Rheum; 2015 Jun; 44(6):680-6. PubMed ID: 25578738
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio as potential makers for digital ulcers and interstitial lung disease in patients with systemic sclerosis: cross-sectional analysis of data from a prospective cohort study.
    Kim A; Kim Y; Kim GT; Ahn E; So MW; Sohn DH; Lee SG
    Rheumatol Int; 2020 Jul; 40(7):1071-1079. PubMed ID: 32424613
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A multicenter trial of recombinant human interferon gamma in patients with systemic sclerosis: effects on cutaneous fibrosis and interleukin 2 receptor levels.
    Polisson RP; Gilkeson GS; Pyun EH; Pisetsky DS; Smith EA; Simon LS
    J Rheumatol; 1996 Apr; 23(4):654-8. PubMed ID: 8730122
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum elastin-derived peptides and anti-elastin antibody in patients with systemic sclerosis.
    Hong YJ; Kim J; Oh BR; Lee YJ; Lee EY; Lee EB; Lee SH; Song YW
    J Korean Med Sci; 2012 May; 27(5):484-8. PubMed ID: 22563211
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.